Awad M, Czer L S C, Mirocha J, Ruzza A, Rafiei M, Reich H, De Robertis M, Rihbany K, Pinzas J, Ramzy D, Arabia F, Trento A, Kobashigawa J, Esmailian F
Division of Cardiology, Cedars Sinai Heart Institute, Los Angeles, California.
Division of Cardiology, Cedars Sinai Heart Institute, Los Angeles, California.
Transplant Proc. 2015 Mar;47(2):485-97. doi: 10.1016/j.transproceed.2014.10.009.
This study investigated the effect of prior sternotomy (PS) on the postoperative mortality and morbidity after orthotopic heart transplantation (HTx).
Of 704 adults who underwent HTx from December 1988 to June 2012 at a single institution, 345 had no PS (NPS group) and 359 had ≥ 1 PS (PS group). Survival, intraoperative use of blood products, intensive care unit (ICU) and hospital stays, frequency of reoperation for bleeding, dialysis, and >48-hour ventilation were examined.
The NPS and PS groups had similar 60-day survival rates (97.1 ± 0.9% vs 95.3 ± 1.1%; P = .20). However, the 1-year survival was higher in the NPS group (94.7 ± 1.2% vs 89.7 ± 1.6%; hazard ratio [HR], 1.98; 95% CI, 1.12-3.49; P = .016). The PS group had longer pump time and more intraoperative blood use (P < .0001 for both). Postoperatively, the PS group had longer ICU and hospital stays, and higher frequencies of reoperation for bleeding and >48-hour ventilation (P < .05 for all comparisons). Patients with 1 PS (1PS group) had a higher 60-day survival rate than those with ≥ 2 PS (2+PS group; 96.7 ± 1.1% vs 91.1 ± 3.0%; HR, 2.70; 95% CI, 1.04-7.01; P = .033). The 2+PS group had longer pump time and higher frequency of postoperative dialysis (P < .05 for both). Patients with prior VAD had lower 60-day (91.1 ± 3.0% vs 97.1 ± 0.9%; P = .010) and 1-year (87.4 ± 3.6% vs 94.7 ± 1.2%; P = .012) survival rates than NPS group patients. Patients with prior CABG had a lower 1-year survival than NPS group patients (89.0 ± 2.3% vs 94.7 ± 1.2%; P = .018).
The PS group had lower 1-year survival and higher intraoperative blood use, postoperative length of ICU and hospital stays, and frequency of reoperation for bleeding than the NPS group. Prior sternotomy increases morbidity and mortality after HTx.
本研究调查了既往胸骨切开术(PS)对原位心脏移植(HTx)术后死亡率和发病率的影响。
1988年12月至2012年6月在单一机构接受HTx的704例成人中,345例无PS(非PS组),359例有≥1次PS(PS组)。检查了生存率、术中血液制品的使用、重症监护病房(ICU)和住院时间、再次手术止血、透析及通气超过48小时的频率。
非PS组和PS组60天生存率相似(97.1±0.9%对95.3±1.1%;P = 0.20)。然而,非PS组1年生存率更高(94.7±1.2%对89.7±1.6%;风险比[HR],1.98;95%可信区间[CI],1.12 - 3.49;P = 0.016)。PS组体外循环时间更长,术中失血更多(两者P均<0.0001)。术后,PS组ICU和住院时间更长,再次手术止血及通气超过48小时的频率更高(所有比较P<0.05)。有1次PS的患者(1PS组)60天生存率高于有≥2次PS的患者(2+PS组;96.7±1.1%对91.1±3.0%;HR,2.70;95%CI, 1.04 - 7.01;P = 0.033)。2+PS组体外循环时间更长,术后透析频率更高(两者P<0.05)。既往使用心室辅助装置(VAD)的患者60天(91.1±3.0%对97.1±0.9%;P = 0.010)和1年(87.4±3.6%对94.7±1.2%;P = 0.012)生存率低于非PS组患者。既往行冠状动脉旁路移植术(CABG)的患者1年生存率低于非PS组患者(89.0±2.3%对94.7±1.2%;P = 0.018)。
与非PS组相比,PS组1年生存率较低,术中失血较多,术后ICU和住院时间较长,再次手术止血频率较高。既往胸骨切开术增加了HTx后的发病率和死亡率。